Navigation Links
Atrium shows a strong financial performance for its first quarter
Date:5/6/2008

Increase of 98% in net earnings from continuing operations during the first

quarter of 2008 to reach 10.5 million US dollars

All amounts in US dollars

QUEBEC CITY, May 6 /PRNewswire-FirstCall/ - Atrium Innovations Inc. (TSX: ATB), a recognized leading developer, manufacturer and marketer of added value products for health and nutrition industries, announced today his financial results for the first quarter of 2008.

During the quarter ended March 31, 2008, Atrium recorded revenues from continuing operations of $65.8 million, which represents an increase of 83.2% compared to revenues of $35.9 million for the corresponding quarter in 2007. Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) from continuing operations for the first quarter of 2008 increased by 90.8% to $18.4 million when compared to US$9.6 million for the same period in 2007. For the quarter ended March 31, 2008, net earnings from continuing operations rose by 97.8% to US$10.5 million when compared to $5.3 million for the same period in 2007. The Company's total net earnings were US$14.7 million, an increase of 70.8% when compared to net earnings of $8.6 million for the corresponding period in 2007. Net earnings per share on a diluted basis for the first quarter of 2008 rose by 69.2% to $0.44 per share, compared to $0.26 per share for the same period in 2007.

"We are very satisfied with the strong financial results for the first quarter as the Mucos integration is going according to plan and as we experienced solid organic growth in the quarter. We have begun the integration of Multicare B.V., which was acquired on February 15. This acquisition respects perfectly our strategic acquisition program. Furthermore we remain confident that we will finalize the sale of the Active Ingredients and Specialty Chemicals Division ("AI&SC") in the upcoming weeks as announced on April 4, allowing us to focus on our Health and Nutrit
'/>"/>

SOURCE Atrium Innovations Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Atrium Innovations to Hold 2008 First Quarter Financial Results Conference Call and Webcast on May 6
2. Atrium Innovations to Hold 2007 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast on February 29
3. Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007
4. Atrium Innovations to Hold 2007 Third Quarter Financial Results Conference Call and Webcast on November 8
5. Atrium Innovations Announces Management Changes
6. A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease
7. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
8. Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention
9. UW paper in Science shows how some solids mimic liquids on nanoscale
10. New research shows that iPods do not interfere with cardiac pacemakers
11. New kind of transistor radios shows capability of nanotube technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...AN FRANCISCO, Dec. 1 Med...I) announced today that in tests involving its pro...to break "6 log" decontamination barriers, this ti... Claustridium difficile and Bacillis subtilis. The... extremely potent sporicidal technology. "The impl...
(Date:12/1/2009)... DNA Genotek, a leading provider of pro...unced that Tepnel Pharmaceutical Services will off... of its nucleic acid extraction and genotyping ser...) December 1, 2009 -- DNA Genotek , a leading pro..., today announced that Tepnel Pharmaceutical Serv...
(Date:12/1/2009)... iCardiac now provides services to thre.... , Rochester, NY (PRWEB)...a global leader in advanced cardiac core lab servi...ve pharmaceutical company has selected iCardiac as...rdiac will provide Highly Automated QT(sm) and Dyn...
(Date:11/30/2009)...OLUMBUS, Ohio, Nov. 30 The Ohio Ca...f the nation,s first minority business early-stage...and December 3, is called "Transforming the Landsc...rly-Stage Capital Summit." It will feature several...usiness leaders and local minority entrepreneurs. ...
Breaking Biology Technology:Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2
... , Introduction , CypHer5 TM is a...-fluorescent at pH 7.4 and maximally fluorescent a...oring internalization of cell surface receptors vi...on (1, 2). , <P ,>In the assay, the re...nizing the tag is then labelled with CypHer5. Alte...
... , Key words: adenoviral vector &#...ll Analyzer ● gene delivery, , ...mary cells can greatly aid secondary screening as ...lopment presents several challenges. Establishing ...erest at detectable levels takes time. In addition...
... , Key words: Melanocortin • ...A Imaging Beads, , Pro-melanocorti... are processed into three major peptide hormone fr...te stimulating hormones, and β-endorphin. The... to activate the MC 5 (melanocortin subtype 5) re...
Other Biology Technology:The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR 2The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR 3The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR 4The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR 5The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR 6Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 2Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 3Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 4Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 5Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 6Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 7Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 8The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System 2The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System 3The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System 4The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System 5
(Date:12/1/2009)...ks by sharks can be solved with a new technique th...y put on their victims, according to a University ...ethod analogous to analyzing human fingerprints, s...mparing shark bites to the jaws and teeth of the p...f the International Shark Attack File, which is ho...
(Date:12/1/2009)...y-led international research team has developed an...neration of solar cells. , Scientists at Monash ...the universities of Wollongong and Ulm in Germany,...ith a three-fold increase in energy conversion eff...ye-sensitised solar cells. , Lead researcher Dr...
(Date:12/1/2009)...ble mystery, and it is a question which has contin...wering plants evolve and how did they come to domi...y Letters reveals the evolutionary trigger which ...etitive advantage over rival species, leading to t... by Dr Tim Brodribb and Dr Taylor Field of the Un...
Breaking Biology News(10 mins):New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Innovation puts next-generation solar cells on the horizon 2How did flowering plants evolve to dominate Earth? 2China Pharma Holdings Inc to Present at Brean Murray China Growth Conference 14881 1China Pharma Holdings Inc to Present at Brean Murray China Growth Conference 14881 2Oncolytics Biotech 28R 29 Inc Announces Unit Offering 14879 1Oncolytics Biotech 28R 29 Inc Announces Unit Offering 14879 2Oncolytics Biotech 28R 29 Inc Announces Unit Offering 14879 3Oncolytics Biotech 28R 29 Inc Announces Unit Offering 14879 4Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes 6360 1Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes 6360 2Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes 6360 3Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes 6360 4
...rst, scientists from Weill Cornell Medical College...ibed the specifics of how brain cells process anti...novel findings could prove useful in the developme...t of psychiatric diseases, most notably in the are...atured as the cover story in a recent issue of Mo...
...versity has received a three-year, $1.6 million gr...ductive science research focused on understanding ...unding fertilization and early embryonic developme...ilization and create a new cell called the zygote....ely forming a new individual. How do the egg and s...
...s, Inc., a fully,integrated critical care biothera...d and Drug Administration (FDA) has granted orphan...use in the reduction of the incidence and,severity...going solid organ,transplantation., Ralf Rosskamp...evelopment for Ikaria, commented, "The designation...
Other Biology News:N.Y. research team discovers how antidepressants and cocaine interact with brain cell targets 2N.Y. research team discovers how antidepressants and cocaine interact with brain cell targets 3W.M. Keck Foundation grant funds reproductive science research 2W.M. Keck Foundation grant funds reproductive science research 3Ikaria(R) Receives FDA Orphan Drug Designation for Inhaled Carbon Monoxide for Delayed Graft Function in Solid Organ Transplants 2
...lly designed to target and display recombinant pro...Displayed proteins can be analyzed for their abili...1 uses the a-agglutinin yeast adhesion receptor wh...ay recombinant protein on the surface of S. cerevi...
15(S)-15-methyl Prostaglandin F2alpha from Cayman Chemical
...yrene divinylbenzene beads for size exclusion chro...ons that require organic eluents. The beads are co...rachloride, dimethylformamide, ketones, aromatics,...thylene, tetrahydrofuran, and trichlorobenzene. Th...
... A BALB/c mouse was immunized with Glutathione-S-...d Storage: Store vial at -20 C prior to opening. ... extended storage. Avoid cycles of freezing and t...r after standing at room temperature. Family: ...
Biology Products: